Literature DB >> 30220561

LncRNA CamK-A Regulates Ca2+-Signaling-Mediated Tumor Microenvironment Remodeling.

Ling-Jie Sang1, Huai-Qiang Ju2, Guang-Ping Liu3, Tian Tian2, Guo-Lin Ma4, Yun-Xin Lu2, Ze-Xian Liu2, Ruo-Lang Pan1, Rui-Hua Li1, Hai-Long Piao5, Jeffrey R Marks6, Luo-Jia Yang1, Qingfeng Yan1, Wenqi Wang7, Jianzhong Shao1, Yubin Zhou4, Tianhua Zhou8, Aifu Lin9.   

Abstract

Cancer cells entail metabolic adaptation and microenvironmental remodeling to survive and progress. Both calcium (Ca2+) flux and Ca2+-dependent signaling play a crucial role in this process, although the underlying mechanism has yet to be elucidated. Through RNA screening, we identified one long noncoding RNA (lncRNA) named CamK-A (lncRNA for calcium-dependent kinase activation) in tumorigenesis. CamK-A is highly expressed in multiple human cancers and involved in cancer microenvironment remodeling via activation of Ca2+-triggered signaling. Mechanistically, CamK-A activates Ca2+/calmodulin-dependent kinase PNCK, which in turn phosphorylates IκBα and triggers calcium-dependent nuclear factor κB (NF-κB) activation. This regulation results in the tumor microenvironment remodeling, including macrophage recruitment, angiogenesis, and tumor progression. Notably, our human-patient-derived xenograft (PDX) model studies demonstrate that targeting CamK-A robustly impaired cancer development. Clinically, CamK-A expression coordinates with the activation of CaMK-NF-κB axis, and its high expression indicates poor patient survival rate, suggesting its role as a potential biomarker and therapeutic target.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ca(2+); LncRNA; NF-κB; PDX; cancer; glycolysis; metabolism; signal transduction; tumor microenvironment

Mesh:

Substances:

Year:  2018        PMID: 30220561     DOI: 10.1016/j.molcel.2018.08.014

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  43 in total

Review 1.  Long non-coding RNAs and nuclear factor-κB crosstalk in cancer and other human diseases.

Authors:  Subash C Gupta; Nikee Awasthee; Vipin Rai; Srinivas Chava; Venugopal Gunda; Kishore B Challagundla
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-10-19       Impact factor: 10.680

Review 2.  Emerging roles of lncRNA in cancer and therapeutic opportunities.

Authors:  Ming-Chun Jiang; Jiao-Jiao Ni; Wen-Yu Cui; Bo-Ya Wang; Wei Zhuo
Journal:  Am J Cancer Res       Date:  2019-07-01       Impact factor: 6.166

Review 3.  Long noncoding RNAs, emerging and versatile regulators of tumor-induced angiogenesis.

Authors:  Jing Zhao; Li Li; Zhong-Ying Han; Zheng-Xin Wang; Lun-Xiu Qin
Journal:  Am J Cancer Res       Date:  2019-07-01       Impact factor: 6.166

Review 4.  The Role of Non-coding RNAs in Oncology.

Authors:  Frank J Slack; Arul M Chinnaiyan
Journal:  Cell       Date:  2019-11-14       Impact factor: 41.582

5.  Mitochondrial long non-coding RNA GAS5 tunes TCA metabolism in response to nutrient stress.

Authors:  Lingjie Sang; Huai-Qiang Ju; Zuozhen Yang; Qiwei Ge; Zhen Zhang; Fangzhou Liu; Luojia Yang; Hangdi Gong; Chengyu Shi; Lei Qu; Hui Chen; Minjie Wu; Hao Chen; Ruihua Li; Qianqian Zhuang; Hailong Piao; Qingfeng Yan; Weishi Yu; Liangjing Wang; Jianzhong Shao; Jian Liu; Wenqi Wang; Tianhua Zhou; Aifu Lin
Journal:  Nat Metab       Date:  2021-01-04

6.  Using Immune-Related lncRNA Signature for Prognosis and Response to Immunotherapy in Cutaneous Melanoma.

Authors:  Ling Xue; Pingfan Wu; Xiaowen Zhao; Xiaojie Jin; Jingjing Wang; Yuxiang Shi; Xiaojing Yang; Yali She; Yaling Li; Changtian Li
Journal:  Int J Gen Med       Date:  2021-10-08

7.  Long non-coding RNA SMASR inhibits the EMT by negatively regulating TGF-β/Smad signaling pathway in lung cancer.

Authors:  Lele Xu; Wenzhong Liu; Tongtong Li; Yuying Hu; Yu Wang; Lijie Huang; Yan Wang; Shujuan Shao; Xuefeng Liu; Qimin Zhan
Journal:  Oncogene       Date:  2021-04-30       Impact factor: 9.867

Review 8.  Long noncoding RNAs in cancer metastasis.

Authors:  S John Liu; Ha X Dang; Daniel A Lim; Felix Y Feng; Christopher A Maher
Journal:  Nat Rev Cancer       Date:  2021-05-05       Impact factor: 60.716

9.  An Immunity-Associated lncRNA Signature for Predicting Prognosis in Gastric Adenocarcinoma.

Authors:  Xiaowen Zhao; Pingfan Wu; Dongling Liu; Changtian Li; Ling Xue; Zhe Liu; Meng Zhu; Jie Yang; Ziyi Chen; Yaling Li; Yali She
Journal:  J Healthc Eng       Date:  2022-04-25       Impact factor: 3.822

10.  A phosphatidic acid-binding lncRNA SNHG9 facilitates LATS1 liquid-liquid phase separation to promote oncogenic YAP signaling.

Authors:  Rui-Hua Li; Tian Tian; Qi-Wei Ge; Xin-Yu He; Cheng-Yu Shi; Jun-Hong Li; Zhen Zhang; Fang-Zhou Liu; Ling-Jie Sang; Zuo-Zhen Yang; Ya-Zhuo Liu; Yan Xiong; Qingfeng Yan; Xu Li; Huai-Qiang Ju; Jian Liu; Liang-Jing Wang; Jian-Zhong Shao; Wenqi Wang; Tianhua Zhou; Aifu Lin
Journal:  Cell Res       Date:  2021-07-15       Impact factor: 46.297

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.